wire - news in brief

« BACK

Health



Results 101 - 150 of 2202.


Psychology - Health - 17.12.2020
Significant increase in psychological stress in the second Covid-19 wave
Significant increase in psychological stress in the second Covid-19 wave
The latest survey by the University of Basel on psychological stress in the second Covid-19 wave has revealed that levels have increased significantly in comparison with the spring of this year. The proportion of people with severe depressive symptoms stood at 9% during lockdown in April, but this figure had risen to 18% in November.

Health - Life Sciences - 16.12.2020

Health - 16.12.2020
COVID-19 Edition of the Science Barometer Switzerland: People Seek Stronger Voice for Science on Pandemic Issues
COVID-19 Edition of the Science Barometer Switzerland: People Seek Stronger Voice for Science on Pandemic Issues
The people of Switzerland have confirmed their faith in science in the present COVID-19 pandemic. They would like to see scientists contributing their expertise more vigorously to the public and political debate. And most of them believe that political decisions on dealing with the pandemic should be based on scientific findings and foundations.

Pharmacology - Health - 16.12.2020
Novartis investigational oral therapy iptacopan (LNP023) receives FDA Breakthrough Therapy Designation for PNH and Rare Pediatric Disease Designation for C3G
Paroxysmal nocturnal hemoglobinuria (PNH) is a rare and life-threatening blood disorder, resulting in debilitating symptoms that can impact patients' quality of life 1-3 C3 glomerulopathy (C3G) is a

Pharmacology - Health - 16.12.2020
Novartis announces positive FDA Advisory Committee recommendation for use of Entresto to treat patients with HFpEF
The Committee voted 12 to 1 that the data presented support the use of Entresto in treatment of patients with heart failure with preserved ejection fraction (HFpEF) Potential Q1 2021 sNDA approval co

Health - Pharmacology - 15.12.2020
New synthetic molecule can kill the flu virus
New synthetic molecule can kill the flu virus
Scientists have developed a synthetic molecule capable of killing the virus that causes influenza. They hope their discovery will lead to an effective drug treatment.

Pharmacology - Health - 15.12.2020
Novartis reports positive topline results from second Phase III trial of Beovu in patients with diabetic macular edema
In Phase III KESTREL study, Beovu (brolucizumab 6 mg) achieved its primary endpoint of non-inferiority to aflibercept 2 mg in change in best-corrected visual acuity (BCVA) at year one (week 52) 1 In

Health - Social Sciences - 14.12.2020

Health - Campus - 14.12.2020
Ticino Scienza, the news portal to "explain excellence"
Over the past two decades the Italian-speaking part of Switzerland has witnessed a strong rise in scientific research activities, both in the private and the public sector.

Health - Administration - 11.12.2020
"Hardly anyone had anticipated this scenario"
The COVID-19 pandemic is putting Swiss crisis management to the test. ETH Professor Andreas Wenger and his team from the Center for Security Studies have investigated in detail how well Switzerland coped with the first phase of the crisis.

Health - Innovation - 11.12.2020

Health - Computer Science - 11.12.2020
Augmented reality in surgery
Augmented reality in surgery
A team at Balgrist University Hospital successfully completed the first holographically navigated spine surgery.

Health - Pharmacology - 11.12.2020
Roche launches laboratory SARS-CoV-2 antigen test to support high-volume testing of suspected COVID-19 patients
The Elecsys SARS-CoV-2 Antigen test is an automated laboratory assay intended as an aid in the diagnosis of active SARS-CoV-2 infection Roche will be able to ramp up to a double-digit million number

Health - Psychology - 10.12.2020
Prioritizing Mental Health during the COVID-19 Pandemic
Prioritizing Mental Health during the COVID-19 Pandemic
The coronavirus is not only a risk for our physical health, but also affects our mental health and emotional well-being.

Health - Pharmacology - 09.12.2020
Novartis Kisqali demonstrates nearly five years median overall survival in metastatic breast cancer
MONALEESA-7 median overall survival (OS) results reinforce Kisqali as the CDK4/6 inhibitor with un rivaled OS evidence 1 Kisqali plus endocrine therapy had a median OS of nearly five years (58&peri

Health - Pharmacology - 09.12.2020
Roche partners with Moderna to include SARS-CoV-2 antibody test in ongoing COVID-19 vaccine trials
Moderna's vaccine triggers an antibody response to the SARS-CoV-2 spike protein The Elecsys Anti-SARS-CoV-2 S test can quantitatively measure the level of antibodies against SARS-CoV-2 in vaccine tri

Pharmacology - Health - 08.12.2020
Novartis investigational STAMP inhibitor asciminib (ABL001) shows superior MMR rate to Bosulif * in chronic myeloid leukemia trial
At 24 weeks, asciminib nearly doubled the major molecular response (MMR) rate compared to Bosulif (bosutinib)*, in patients resistant to, or intolerant of, at least two prior tyrosine kinase inhibito

Health - 08.12.2020
COVID-19: persistent symptoms in one third of cases
Physicians in Geneva have shown that some of the troublesome symptoms of COVID-19 could last more than 6 weeks, even in patients without underlying risk factors.

Pharmacology - Health - 08.12.2020
Roche presents new data from its bispecific antibody portfolio across a range of blood cancers
Latest data to be presented at ASH 2020 includes results in non-Hodgkin lymphoma and heavily pre-treated multiple myeloma Portfolio includes two CD20xCD3 bispecifics, mosunetuzumab and glofitamab, an

Pharmacology - Health - 05.12.2020
Novartis analyses confirm benefit of Kymriah with clinically meaningful rates of complete response seen in patients with certain advanced lymphomas
Interim analysis from the investigational ELARA study shows, 65% of patients with r/r follicular lymphoma evaluated for efficacy achieved a complete response and the overall response rate was 83% 1 L

Pharmacology - Health - 04.12.2020
Novartis announces first data from REACH3 trial showing Jakavi (ruxolitinib) significantly improved outcomes in patients with steroid-resistant/dependent chronic GvHD
Results of REACH3 trial also demonstrate significant improvements in failure-free survival (FFS) and patient-reported symptoms 1 Chronic graft-versus-host disease (GvHD) is a life-threatening complic

Health - Economics / Business - 04.12.2020
Swiss TPH Symposium: Reshaping Healthcare Supply Chains
Swiss TPH Symposium: Reshaping Healthcare Supply Chains
Strong and resilient supply chains ensure the provision of quality health products and vaccines to patients, making them a central component of health systems.

Innovation - Health - 03.12.2020
Technical know-how meets humanitarian aid
Technical know-how meets humanitarian aid
Engineers from the ETH Feasibility Lab are working together with the ICRC to develop a prosthetic leg that allows easy replacement of its wearing part.

Health - Pharmacology - 02.12.2020
Roche receives FDA Emergency Use Authorization for new test to measure the level of SARS-CoV-2 antibodies
Elecsys Anti-SARS-CoV-2 S test specifically detects antibodies against the SARS-CoV-2 spike protein The spike protein is the target of many COVID-19 vaccines in development This test may help identif

Health - Pharmacology - 30.11.2020
Taco mattresses take the pressure off hospitals
Taco mattresses take the pressure off hospitals
During the lockdown last spring, Julian Ferchow put his doctoral project aside to help relieve the strain on hospitals.

Health - Pharmacology - 25.11.2020
Infusion more effective than tablets: Treatment of iron anaemia in rural Africa
Infusion more effective than tablets: Treatment of iron anaemia in rural Africa
Iron-deficiency anaemia is a major concern in low income countries, especially for women. A study conducted in Tanzania has now demonstrated the advantage of iron infusion therapy over the usual treatment with iron tablets.

Health - Pharmacology - 25.11.2020
Tackling pandemic threats proactively
If we are to minimize the impact of future disease outbreaks, we must recognize the importance of immunization and invest in preemptive vaccine development, writes Tim Keys.

Health - Environment - 18.11.2020
How Particulate Matter injures airways and promotes exacerbation of pulmonary diseases
How Particulate Matter injures airways and promotes exacerbation of pulmonary diseases
An international study led by the University of Bern has investigated the effects of ambient Particulate Matter (PM) from human and natural sources on human lung cells.

Health - Pharmacology - 18.11.2020
Coronavirus: simplified, faster generation of SwissCovid app codes
The process of generating covidcodes has been significantly simplified and accelerated. Persons who have tested positive can enter their code into the SwissCovid app to inform other app users of possible exposure to the virus.

Pharmacology - Health - 13.11.2020
New Novartis analyses for investigational inclisiran demonstrate consistently effective and sustained LDL-C reduction at month 17 regardless of age and gender
Pooled data analyses from Phase III ORION-9, -10 and -11 showed that inclisiran consistently reduced low-density lipoprotein cholesterol (LDL-C) by approximately 51% in both male and female adult p

Pharmacology - Health - 13.11.2020
Results from real-world data and post-hoc analysis of Novartis Beovu pivotal trials presented at AAO 2020
Initial findings on patient characteristics and event likelihood provide insights related to Beovu use in wet AMD 1,2 Follows establishment of multi-disciplinary expert coalition and Novartis commi